Influenza A (#588)
Laufzeit: 01.01.2016 - 31.12.2017
imported
Kurzfassung
A phase 2, randomized, double blind trial of MHAA4549A, a monoclonal antibody, in combination with Oseltamivir versus Oseltamivir for treatment of severe influenza A infection
